Investor News
February 17, 2003 - Board changes
Cyprotex plc announced today that Dr Colin Picton will become non-executive Chairman of the Company with immediate effect, following the resignation of Jeremy Scudamore. Colin is already familiar with Cyprotex's business, having served as a non-executive Director of the Company since February 2002.
Cyprotex also announces Dr Mark Egerton's intention to step down as Chief Executive Officer in order to pursue other business interests. Mark will continue to fulfil his executive responsibilities while the Board actively searches for a replacement.
Dr David Leahy, Chief Scientific Officer and Founder of Cyprotex plc, said:
"The Board is pleased to welcome Colin as non-executive Chairman and would like to thank Jeremy and Mark for their significant contribution to the Company and wish them every success in the future."
- Ends -
Cyprotex plc
John Nicholson, Chief Operating Officer
Tel: +44 (0) 1625 505 100
Bankside
Henry Harrison-Topham - henry.ht@bankside.com
Tel: +44 (0) 20 7444 4140
